X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (38381) 38381
Newspaper Article (120) 120
Book Chapter (115) 115
Dissertation (11) 11
Book / eBook (9) 9
Magazine Article (5) 5
Conference Proceeding (3) 3
Government Document (3) 3
Publication (2) 2
Book Review (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24398) 24398
animals (17921) 17921
female (10646) 10646
male (10279) 10279
mice (9600) 9600
matrix metalloproteinases (9449) 9449
expression (9382) 9382
cell biology (7266) 7266
gene expression (7093) 7093
extracellular matrix (6462) 6462
oncology (6353) 6353
proteins (6094) 6094
cancer (5366) 5366
biochemistry & molecular biology (5249) 5249
matrix metalloproteinase 9 - metabolism (5219) 5219
cell line, tumor (5115) 5115
metastasis (4870) 4870
middle aged (4851) 4851
matrix metalloproteinase (4837) 4837
cells, cultured (4698) 4698
matrix metalloproteinase 2 - metabolism (4478) 4478
inflammation (4427) 4427
collagen (4324) 4324
matrix metalloproteinase 9 - genetics (4291) 4291
research (4256) 4256
analysis (4174) 4174
signal transduction (4144) 4144
adult (4092) 4092
extracellular-matrix (4041) 4041
apoptosis (3992) 3992
research article (3885) 3885
activation (3872) 3872
rats (3652) 3652
medicine (3567) 3567
matrix metalloproteinase 2 - genetics (3546) 3546
gene-expression (3540) 3540
aged (3535) 3535
genetic aspects (3395) 3395
angiogenesis (3339) 3339
rna, messenger - metabolism (3309) 3309
invasion (3297) 3297
immunohistochemistry (3202) 3202
multidisciplinary sciences (3199) 3199
cells (3186) 3186
cell proliferation (2930) 2930
metalloproteinase (2926) 2926
disease models, animal (2795) 2795
health aspects (2771) 2771
physiological aspects (2765) 2765
tumors (2743) 2743
medicine, research & experimental (2738) 2738
reverse transcriptase polymerase chain reaction (2734) 2734
extracellular matrix - metabolism (2714) 2714
neoplasm invasiveness (2703) 2703
in-vitro (2684) 2684
mice, inbred c57bl (2648) 2648
rna, messenger - genetics (2623) 2623
rodents (2611) 2611
science (2610) 2610
cytokines (2577) 2577
development and progression (2533) 2533
matrix metalloproteinases - metabolism (2519) 2519
kinases (2506) 2506
biology (2454) 2454
fibroblasts (2388) 2388
growth (2347) 2347
gene expression regulation, neoplastic (2331) 2331
up-regulation (2253) 2253
immunology (2200) 2200
fibrosis (2162) 2162
physiology (2161) 2161
studies (2159) 2159
genes (2136) 2136
mice, knockout (2130) 2130
care and treatment (2108) 2108
blotting, western (2098) 2098
migration (2070) 2070
cell line (2058) 2058
pathology (2046) 2046
enzymes (2002) 2002
cell adhesion & migration (1995) 1995
tissue inhibitor (1989) 1989
cell movement (1929) 1929
phosphorylation (1903) 1903
disease (1859) 1859
inhibition (1854) 1854
stem cells (1833) 1833
proliferation (1828) 1828
prognosis (1757) 1757
breast cancer (1746) 1746
risk factors (1746) 1746
pathogenesis (1729) 1729
growth factors (1706) 1706
cell migration (1703) 1703
gene expression regulation (1693) 1693
gelatinase b (1687) 1687
biochemistry (1686) 1686
transfection (1657) 1657
down-regulation (1644) 1644
polymerase chain reaction (1631) 1631
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (38407) 38407
Chinese (376) 376
Japanese (157) 157
Russian (40) 40
German (22) 22
Polish (11) 11
Portuguese (10) 10
French (9) 9
Spanish (7) 7
Korean (5) 5
Czech (2) 2
Hebrew (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Romanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Biological Chemistry, ISSN 0021-9258, 08/2009, Volume 284, Issue 34, pp. 23001 - 23011
.... Current evidence suggests that type I collagenolysis is mediated by secreted as well as membrane-anchored members of the matrix metalloproteinase (MMP) gene family... 
1-MATRIX METALLOPROTEINASE | TYPE-1 MATRIX-METALLOPROTEINASE | SUBSTRATE DEGRADATION | GELATINASE-A | CELL-MIGRATION | CYSTEINE PROTEINASES | BIOCHEMISTRY & MOLECULAR BIOLOGY | TARGETED MUTATION | EXTRACELLULAR-MATRIX | DEFICIENT MICE | MEDIATED INHIBITION | Matrix Metalloproteinase 9 - physiology | Matrix Metalloproteinase 8 - physiology | Matrix Metalloproteinase 2 - physiology | Tissue Inhibitor of Metalloproteinase-2 - genetics | Protease Inhibitors - pharmacology | Matrix Metalloproteinase 9 - genetics | Plasminogen - pharmacology | Matrix Metalloproteinase 16 - genetics | Membrane Proteins - metabolism | Fibroblasts - metabolism | Matrix Metalloproteinase 8 - genetics | Collagen Type I - metabolism | Proto-Oncogene Proteins c-sis | Matrix Metalloproteinase 13 - genetics | Mice, Inbred C57BL | Cells, Cultured | Platelet-Derived Growth Factor - pharmacology | Microscopy, Electron | Reverse Transcriptase Polymerase Chain Reaction | Mice, Knockout | Tissue Inhibitor of Metalloproteinase-2 - physiology | Cell Movement - drug effects | Matrix Metalloproteinase 2 - genetics | Matrix Metalloproteinase 14 - physiology | Animals | Matrix Metalloproteinase 16 - physiology | Matrix Metalloproteinase 13 - physiology | Fibroblasts - drug effects | Fluorescent Antibody Technique | Matrix Metalloproteinase 14 - genetics | Cell Proliferation - drug effects | Mice | Collagenases - metabolism | Molecular Basis of Cell and Developmental Biology
Journal Article
Experimental Cell Research, ISSN 0014-4827, 08/2012, Volume 318, Issue 13, pp. 1517 - 1527
... of the mRNA/protein expression and activity of metalloproteinases (MMPs), their tissue inhibitors (TIMPs... 
Metastasis | Co-culture insert | HNSCC | Matrix remodeling | HEAD | ACTIVATION | TRANSCRIPTION | OVARIAN-CANCER | MESENCHYMAL TRANSITION | CELL BIOLOGY | LUNG-CANCER | SYNOVIAL FIBROBLASTS | ONCOLOGY | GENE-EXPRESSION | STROMAL FIBROBLASTS | CLINICAL-SIGNIFICANCE | Matrix Metalloproteinases - genetics | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Coculture Techniques | Humans | Gene Expression Regulation, Neoplastic | Mouth Neoplasms - metabolism | Periodontal Ligament - metabolism | RNA, Messenger - metabolism | RNA, Neoplasm - metabolism | Tissue Inhibitor of Metalloproteinases - genetics | Matrix Metalloproteinase 9 - metabolism | Matrix Metalloproteinase 9 - genetics | Mouth Neoplasms - genetics | Fibroblasts - metabolism | Paracrine Communication | Matrix Metalloproteinase 2 - metabolism | Neoplasm Invasiveness | RNA, Messenger - genetics | Cells, Cultured | Fibroblasts - pathology | Matrix Metalloproteinase 14 - metabolism | Tissue Inhibitor of Metalloproteinases - metabolism | Periodontal Ligament - pathology | Gene Expression Regulation, Enzymologic | Matrix Metalloproteinase 2 - genetics | Models, Biological | Matrix Metalloproteinase 14 - genetics | Cell Line, Tumor | Mouth Neoplasms - pathology | RNA, Neoplasm - genetics | Matrix Metalloproteinases - metabolism | Fibronectins | Squamous cell carcinoma | Care and treatment | Dexamethasone | Carcinoma | Corticosteroids | RNA | Transforming growth factors | Gene expression | Analysis | Tumors | Integrins | Cancer | Proteins | Enzymes | Oral cancer | Ligaments | 1MMP, matrix metalloproteinase | MT1-MMP, membrane-type 1 matrix metalloproteinase | EMT, epithelial-to-mesenchymal transition | HNSCC, head and neck squamous cell carcinoma | ECM, extracellular matrix | FN, fibronectin | DEX, dexamethasone | COX-2, prostaglandin-endoperoxide synthase 2 | CAFs, carcinoma-associated fibroblasts | IMVD, intratumoral microvessel density | TGF-β1, transforming growth factor-β1 | IL, interleukin | PDL, periodontal ligament (PDL) fibroblasts | FBS, foetal bovine serum | OSCC, oral squamous cell carcinoma | TIMP, tissue inhibitor of metalloproteinases | LTBP-1, latent-transforming growth factor beta-binding protein
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 08/2006, Volume 8, Issue 5, pp. R142 - R142
.... The main enzymes involved belong to the metalloproteinase family, specifically the matrix metalloproteinases (MMPs... 
IN-VITRO | ONCOSTATIN-M | MATRIX-METALLOPROTEINASE | PROTECTS CARTILAGE | GENE-EXPRESSION | PROTEOGLYCAN CATABOLISM | ARTICULAR CHONDROCYTES | NECROSIS-FACTOR-ALPHA | EXTRACELLULAR-MATRIX | RHEUMATOLOGY | BOVINE NASAL CARTILAGE | Matrix Metalloproteinase 12 - genetics | Gene Expression Profiling | Gene Expression Regulation, Enzymologic - physiology | Metalloproteases - metabolism | Tissue Inhibitor of Metalloproteinase-2 - genetics | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Tissue Inhibitor of Metalloproteinase-2 - metabolism | Matrix Metalloproteinase 9 - metabolism | Nasal Septum - cytology | Cattle | Matrix Metalloproteinase 9 - genetics | Matrix Metalloproteinase 16 - genetics | Tissue Inhibitor of Metalloproteinase-3 - metabolism | Up-Regulation - physiology | Cartilage - cytology | Cartilage - physiology | Matrix Metalloproteinase 1 - genetics | Organ Culture Techniques | Tissue Inhibitor of Metalloproteinase-3 - genetics | Matrix Metalloproteinase 2 - metabolism | Matrix Metalloproteinase 13 - genetics | Matrix Metalloproteinase 16 - metabolism | Metalloproteases - genetics | Matrix Metalloproteinase 3 - metabolism | Matrix Metalloproteinase 12 - metabolism | Matrix Metalloproteinase 14 - metabolism | Matrix Metalloproteinase 13 - metabolism | Down-Regulation - physiology | Collagen - metabolism | Matrix Metalloproteinase 2 - genetics | Tissue Inhibitor of Metalloproteinase-1 - genetics | ADAM Proteins - metabolism | Animals | Homeostasis - physiology | Matrix Metalloproteinase 14 - genetics | ADAM Proteins - genetics | Matrix Metalloproteinase 1 - metabolism | Matrix Metalloproteinase 3 - genetics
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 5, p. e20164
... agent [1], [2], [... 
INACTIVATION | APOPTOSIS | ACTIVATION | ANGIOGENESIS | MULTIDISCIPLINARY SCIENCES | KINASE | LINE | CYCLE ARREST | PROLIFERATION | AKT | PROGRESSION | Prostatic Neoplasms - metabolism | Humans | Immunoblotting | JNK Mitogen-Activated Protein Kinases - metabolism | Male | NF-kappa B - metabolism | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - genetics | Tissue Inhibitor of Metalloproteinase-2 - genetics | Tissue Inhibitor of Metalloproteinase-2 - metabolism | Matrix Metalloproteinase 9 - metabolism | Matrix Metalloproteinase 7 - metabolism | Basigin - genetics | Matrix Metalloproteinase 9 - genetics | Polymerase Chain Reaction | JNK Mitogen-Activated Protein Kinases - genetics | Phosphatidylinositol 3-Kinase - metabolism | Diosgenin - pharmacology | Matrix Metalloproteinase 2 - metabolism | Cell Movement - drug effects | Matrix Metalloproteinase 2 - genetics | Matrix Metalloproteinase 7 - genetics | NF-kappa B - genetics | Phosphatidylinositol 3-Kinase - genetics | Basigin - metabolism | Cell Line, Tumor | Progesterone | Metastasis | Vascular endothelial growth factor | Health aspects | Prostate cancer | Apoptosis | Transcription factors | Boyden chamber | Matrix metalloproteinases | Leukocyte migration | AKT protein | Assaying | Metastases | Proteins | Angiogenesis | Cell growth | Gelatin | Inhibition | Enzymes | NF-κB protein | Medical technology | Wound healing | Gene expression | 1-Phosphatidylinositol 3-kinase | Pharmacy | Cell migration | Cell proliferation | Biotechnology | Tissue inhibitor of metalloproteinases | Phosphorylation | Colorectal cancer | Science | mRNA | Matrix metalloproteinase | Kinases | Cell adhesion & migration | Carcinogens | Cell cycle | Fenugreek | Metalloproteinase | Tumor cells | Extracellular signal-regulated kinase | c-Jun protein | Breast cancer | Endothelial cells | Gelatinase B | Gelatinase A | Signaling | Collagen | Prostate | Tumors | Cancer
Journal Article
Matrix biology, ISSN 0945-053X, 2011, Volume 30, Issue 2, pp. 145 - 153
Aggrecan degradation in articular cartilage occurs predominantly through proteolysis and has been attributed to the action of members of the matrix metalloproteinase (MMP... 
MMP | ADAMTS | Interglobular domain | Chondroitin-sulfate-2 region | Aggrecan catabolism | RHEUMATOID-ARTHRITIS | PROTEOLYTIC CLEAVAGE | CLEAVAGE SITE | ACTIVATION MECHANISMS | LARGE AGGREGATING PROTEOGLYCAN | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL BIOLOGY | HUMAN ARTICULAR-CARTILAGE | MATRIX METALLOPROTEINASES | OSTEOARTHRITIC CARTILAGE | ONCOSTATIN-M | Matrix Metalloproteinases, Secreted - metabolism | Interleukin-1beta - pharmacology | Phenylmercuric Acetate - pharmacology | Matrix Metalloproteinase 12 - genetics | Cartilage - drug effects | Oncostatin M - pharmacology | Matrix Metalloproteinase 9 - metabolism | Matrix Metalloproteinase 7 - metabolism | Cattle | Isoenzymes - metabolism | Matrix Metalloproteinase 8 - metabolism | Gelatinases - metabolism | Matrix Metalloproteinase 1 - genetics | Recombinant Proteins - metabolism | Endopeptidases - metabolism | Matrix Metalloproteinase 8 - genetics | Peptide Fragments - metabolism | Isoenzymes - genetics | Matrix Metalloproteinase 2 - metabolism | Matrix Metalloproteinase 3 - metabolism | Aggrecans - metabolism | Matrix Metalloproteinase 12 - metabolism | Cartilage - metabolism | Aggrecans - genetics | ADAM Proteins - metabolism | Enzyme Precursors - metabolism | Matrix Metalloproteinase 7 - genetics | Animals | Endopeptidases - genetics | Matrix Metalloproteinases, Secreted - genetics | Phenylmercuric Acetate - analogs & derivatives | ADAM Proteins - genetics | Cartilage - enzymology | Matrix Metalloproteinase 1 - metabolism | Matrix Metalloproteinase 3 - genetics
Journal Article
PloS one, ISSN 1932-6203, 2012, Volume 7, Issue 8, p. e42714
...), extracellular signal-regulated kinase (ERK) 1/2 phosphorylation (pERK) and a neuronal nitric oxide (NO) synthase (nNOS... 
RENAL FIBROSIS | LUNG FIBROSIS | COLLAGEN | MULTIDISCIPLINARY SCIENCES | GROWTH | INTERSTITIAL FIBROSIS | TISSUE INHIBITORS | SMOOTH-MUSCLE-CELLS | NITRIC-OXIDE PATHWAY | HORMONE RELAXIN | FIBROBLASTS | Relaxin - metabolism | Matrix Metalloproteinases - genetics | Receptors, G-Protein-Coupled - metabolism | Humans | Male | Receptors, Peptide - genetics | Matrix Metalloproteinase 9 - metabolism | Relaxin - genetics | Matrix Metalloproteinase 9 - genetics | Fibroblasts - metabolism | Cell Line | Matrix Metalloproteinase 2 - metabolism | Matrix Metalloproteinase 13 - genetics | Cells, Cultured | Rats | Kidney - cytology | Signal Transduction - genetics | Extracellular Signal-Regulated MAP Kinases | Rats, Sprague-Dawley | Matrix Metalloproteinase 13 - metabolism | Mice, Knockout | Matrix Metalloproteinase 2 - genetics | Animals | Cyclic GMP - metabolism | Nitric Oxide Synthase Type I - metabolism | Signal Transduction - physiology | Fibroblasts - cytology | Mice | Nitric Oxide Synthase Type I - genetics | Receptors, G-Protein-Coupled - genetics | Matrix Metalloproteinases - metabolism | Nitric Oxide - metabolism | Receptors, Peptide - metabolism | Physiological aspects | Genetic aspects | Research | Transforming growth factors | Metalloenzymes | Nitric oxide | Neurosciences | Phosphorylation | Matrix metalloproteinases | Guanosine | Smooth muscle | Genomes | Arthritis | Biochemistry | Matrix metalloproteinase | Guanylate cyclase | Western blotting | Signal transduction | Arginine | Gelatin | Rodents | Cyclic GMP | Fibroblasts | Metalloproteinase | Interstitial collagenase | Kidneys | Extracellular signal-regulated kinase | Collagenase 3 | Nitric-oxide synthase | Gelatinase B | NG-Nitroarginine methyl ester | Gelatinase A | Signaling | Inhibitors | Human performance | Collagen | Isoforms | Fibrosis | Skin | Aberration | Molecular biology | Ornithine
Journal Article
PloS one, ISSN 1932-6203, 2013, Volume 8, Issue 5, p. e63165
Matrix metalloproteinases (MMPs) contribute to cancer through their involvement in cancer invasion and metastasis... 
POPULATION | MATRIX-METALLOPROTEINASE-2 | WOMEN | MULTILOCUS GENOTYPE DATA | POLYMORPHISMS | MULTIDISCIPLINARY SCIENCES | SUSCEPTIBILITY | INFERENCE | MMP-9 | Genetic Predisposition to Disease - genetics | Matrix Metalloproteinases - genetics | Humans | Middle Aged | Risk Factors | Hispanic Americans | European Continental Ancestry Group | Matrix Metalloproteinase 2 - genetics | Breast Neoplasms - enzymology | Breast Neoplasms - genetics | Matrix Metalloproteinase 9 - genetics | Polymorphism, Single Nucleotide - genetics | Adult | Female | Matrix Metalloproteinase 3 - genetics | Matrix Metalloproteinase 1 - genetics | Women | Societies, clubs, etc | Oncology, Experimental | Genes | Development and progression | Breast cancer | Metastasis | Research | Risk factors | Women's organizations | Genetic research | Genetic aspects | Single nucleotide polymorphisms | Native Americans | Cancer | Health care | Matrix metalloproteinases | Single-nucleotide polymorphism | Matrix metalloproteinase | Medical diagnosis | Epidemiology | Population genetics | Metastases | Population | Genetics | Metalloproteinase | Age | Medical research | Stromelysin 1 | Health risks | Genetic diversity | Preventive medicine | Cultural differences | Survival | Minority & ethnic groups | Gelatinase B | Gelatinase A | Disease prevention | Studies | Ethnicity | Womens health | Biomarkers | Hormone replacement therapy | Health risk assessment | Tumors | Health disparities
Journal Article
BMC Cancer, ISSN 1471-2407, 01/2009, Volume 9, Issue 1, pp. 20 - 20
.... The role of matrix metalloproteinases ( MMPs), tissue inhibitors of MMPs (TIMPs) and Reversion-inducing cysteine-rich protein with Kazal motifs ( RECK... 
KAZAL MOTIFS | MATRIX METALLOPROTEINASES | LUNG-CANCER | IN-VITRO | CYSTEINE-RICH PROTEIN | ONCOLOGY | RT-PCR | EXTRACELLULAR-MATRIX | PROGNOSTIC-SIGNIFICANCE | CARCINOMA | RNA EXPRESSION | Matrix Metalloproteinases - genetics | Tissue Inhibitor of Metalloproteinase-1 - biosynthesis | Humans | Membrane Glycoproteins - biosynthesis | GPI-Linked Proteins | Tissue Inhibitor of Metalloproteinase-2 - genetics | Breast Neoplasms - metabolism | Tissue Inhibitor of Metalloproteinases - genetics | Matrix Metalloproteinase 14 - biosynthesis | RNA, Messenger - biosynthesis | Breast Neoplasms - enzymology | Neoplasm Metastasis | Matrix Metalloproteinase 9 - genetics | Tissue Inhibitor of Metalloproteinase-2 - biosynthesis | Matrix Metalloproteinase 2 - biosynthesis | Tissue Inhibitor of Metalloproteinases - biosynthesis | Matrix Metalloproteinases - biosynthesis | Matrix Metalloproteinase 9 - biosynthesis | Neoplasm Invasiveness | RNA, Messenger - genetics | Reverse Transcriptase Polymerase Chain Reaction | Membrane Glycoproteins - genetics | Matrix Metalloproteinase 2 - genetics | Tissue Inhibitor of Metalloproteinase-1 - genetics | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Matrix Metalloproteinase 14 - genetics | Cell Line, Tumor | Care and treatment | Prognosis | Enzyme inhibitors | Proteases | Breast cancer | Genetic aspects | Dosage and administration | Research | Gene expression | Health aspects
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e80883
... and radiation therapy are a critical treatment modality in the early stage of OSCC [2]. Despite advances in therapy, OSCC is still characterized as recurrent and metastasis... 
MIGRATION | INACTIVATION | INVASION | COLORECTAL-CANCER | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | TISSUE INHIBITOR | FLAVONOIDS | PROGNOSTIC-SIGNIFICANCE | NF-KAPPA-B | CARCINOMA | Transcription, Genetic - drug effects | Protein Binding - genetics | Nitriles - pharmacology | DNA, Neoplasm - metabolism | Humans | Cell Survival - genetics | Extracellular Signal-Regulated MAP Kinases - metabolism | RNA, Messenger - metabolism | Transcription Factor AP-1 - metabolism | Cell Movement - genetics | Tissue Inhibitor of Metalloproteinase-2 - metabolism | Protein Binding - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Phosphorylation - drug effects | Mouth Neoplasms - enzymology | Cell Survival - drug effects | Butadienes - pharmacology | Matrix Metalloproteinase 2 - metabolism | Neoplasm Invasiveness | RNA, Messenger - genetics | Signal Transduction - genetics | Down-Regulation - drug effects | Cell Movement - drug effects | Matrix Metalloproteinase 2 - genetics | Matrix Metalloproteinase Inhibitors - pharmacology | Signal Transduction - drug effects | Cell Line, Tumor | Mouth Neoplasms - pathology | Kaempferols - pharmacology | Prevention | Medical research | Care and treatment | Squamous cell carcinoma | RNA | Analysis | Medicine, Experimental | Metastasis | Cardiovascular diseases | Mouth cancer | Cancer | Biotechnology | Food plants | Transcription factors | Tongue | Phosphorylation | Transcription | Oral cancer | Laboratories | Gene regulation | Colorectal cancer | Otolaryngology | Biochemistry | Matrix metalloproteinase | Tissue inhibitor of metalloproteinase 2 | Cancer therapies | Metastases | Angiogenesis | Signal transduction | Cell cycle | Physiology | Metalloproteinase | Plant-based foods | Food | Kaempferol | Activator protein 1 | Melanoma | Extracellular signal-regulated kinase | c-Jun protein | Plant protection | Breast cancer | Gene expression | Gelatinase A | Signaling | Bone cancer | Chemotherapy | Flavonoids | Hospitals | Molecular modelling | Cell migration | Apoptosis
Journal Article
Biomaterials, ISSN 0142-9612, 2014, Volume 35, Issue 26, pp. 7622 - 7634
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 7, p. e21816
Background: IL-17A is a pro-inflammatory cytokine that plays important role in inflammatory disease pathology and tumor microenvironment. The aim of this study... 
RHEUMATOID-ARTHRITIS | ACTIVATED MONOCYTES | MULTIDISCIPLINARY SCIENCES | IL-17 | EXPANSION | KAPPA-B | TUMOR-GROWTH | CANCER | T-CELLS | PROGRESSION | TH17 CELLS | Gene Expression Regulation, Enzymologic - drug effects | Multivariate Analysis | Prognosis | Humans | Middle Aged | Epithelial-Mesenchymal Transition - drug effects | Male | NF-kappa B - metabolism | Interleukin-17 - pharmacology | Neoplasm Metastasis | Matrix Metalloproteinase 9 - genetics | Carcinoma, Hepatocellular - genetics | Enzyme Induction - drug effects | Female | Liver Neoplasms - pathology | Gene Expression Regulation, Neoplastic - drug effects | Liver Neoplasms - enzymology | Matrix Metalloproteinase 2 - biosynthesis | Matrix Metalloproteinase 9 - biosynthesis | Liver Neoplasms - genetics | Neoplasm Invasiveness | Carcinoma, Hepatocellular - enzymology | Recombinant Proteins - pharmacology | Up-Regulation - drug effects | Cell Movement - drug effects | Matrix Metalloproteinase 2 - genetics | Carcinoma, Hepatocellular - pathology | Survival Analysis | Aged | Cell Proliferation - drug effects | Immunohistochemistry | Medical research | Interleukins | Analysis | Medicine, Experimental | Development and progression | Hepatoma | Health sciences | Transcription factors | Matrix metalloproteinases | Transcription | Leukocyte migration | Laboratories | Interleukin | Oncology | Hepatocellular carcinoma | Metastasis | Tissues | Metastases | Independent sample | Morphogenesis | Liver cancer | Signal transduction | Lymphocytes | NF-κB protein | Cytokines | Breast cancer | Gelatinase B | Gelatinase A | Medicine | Studies | Survival analysis | Signaling | Medical prognosis | Kidney cancer | Cell migration
Journal Article